Shanghai Haohai Biological Technology (6826 HK)

136

Analysis

Health Care • China

Shanghai Haohai Biological Technology engages in the research, development, manufacture, and sale of biomedical materials and pharmaceutical products. The company focuses on therapeutic areas including ophthalmology, medical aesthetics and wound care, orthopedics, and anti-adhesion and hemostasis, with key products such as intraocular lenses, hyaluronic acid dermal fillers, and sodium hyaluronate injections. It is headquartered in Shanghai, China, and was founded in 2007.

Refresh

Exchange Announcement • 12 Oct 2026 16:30

Date Of Board Meeting

Exchange Announcement • 21 Sep 2026 17:20

Next Day Disclosure Return

Exchange Announcement • 18 Sep 2026 17:20

Next Day Disclosure Return

Exchange Announcement • 11 Sep 2026 17:04

Next Day Disclosure Return

Exchange Announcement • 10 Sep 2026 17:40

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00